Cost Burden Analysis: To calculate the income burden faced in each state, we compared the average monthly out-of-pocket price of GLP-1 medications (pricing assumptions reflect a blended cash-pay range of approximately $150$450 per month, with $350 used as a common injectable reference point rather than a universal baseline) to each states per capita annual income
Exenatide and sitagliptin are not associated with increased risk of acute renal failure: a retrospective claims analysis
Unfortunately, these excess calories and processed foods can also be harmful to your health and your liver
Neuropharmacology 86, 2230
In a 12-month study of 339 Second Nature members published in JMIR Formative Research, participants on tirzepatide lost an average of 22.1% of their body weight, and those on semaglutide lost 17.1% 11
The net effect is that they reduce physical hunger and the non-physical desire to eat, as the reward we get from food is diminished